Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● Its low valuation, with P/E ratio at 3.8 and 6.47 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company shows low valuation levels, with an enterprise value at 0.25 times its sales.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company sustains low margins.

● The company is not the most generous with respect to shareholders' compensation.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.